BRANFORD, Conn.--(BUSINESS WIRE)--Neurogen Corporation (Nasdaq: NRGN), a drug discovery and development company, announced today that Stephen R. Davis, Executive Vice President and Chief Operating Officer, will present a Company and pipeline overview at the BIO CEO & Investor Conference 2007 on Wednesday, February 14 at 11:15 a.m. EST.
